Barclays’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $48K | Sell |
|
|||||
|
2023
Q4 | $78K | Buy |
|
|||||
|
2023
Q3 | $41K | Sell |
|
|||||
|
2023
Q2 | $104K | Sell |
|
|||||
|
2023
Q1 | $179K | Sell |
|
|||||
|
2022
Q4 | $350K | Buy |
|
|||||
|
2022
Q3 | $575K | Buy |
|
|||||
|
2022
Q2 | $326K | Buy |
|
|||||
|
2022
Q1 | $295K | Sell |
|
|||||
|
2021
Q4 | $987K | Buy |
|
|||||
|
2021
Q3 | $679K | Buy |
|
|||||
|
2021
Q2 | $123K | Sell |
|
|||||
|
2021
Q1 | $773K | Buy |
|
|||||
|
2020
Q4 | $492K | Sell |
|
|||||
|
2020
Q3 | $404K | Buy |
|
|||||
|
2020
Q2 | $450K | Buy |
|
|||||
|
2020
Q1 | $276K | Sell |
|
|||||
|
2019
Q4 | $800K | Buy |
|
|||||
|
2019
Q3 | $401K | Sell |
|
|||||
|
2019
Q2 | $428K | Buy |
|